Market cap
$22.994 B
$113.44 +0.63%
Close of 8 Oct 2026
As of 8 Oct 2026, Incyte (INCY) has a market capitalization of $23.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$5.14B
#655 by revenue
Earnings
$1.29B
#323 by earnings
Shares outstanding
202,697,746
Latest filing cover page
P/E ratio
17.9
Cap ÷ net income
Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap
All 12 →- #1IqviaIQV$42.5B
- #2IncyteINCY$23.0B
- #3MedpaceMEDP$16.9B
- #4Charles River Laboratories InternationalCRL$14.3B
- #5IconICLR$12.6B
What if Incyte were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Incyte are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Oct 2026. Read the methodology.